North America to Lead Global Veterinary Oncology Market over the Decade
Rockville, Oct. 06, 2023 (GLOBE NEWSWIRE) — As per a research executed by expert analysts at Fact.MR, a supplier of market analysis and aggressive intelligence, the worldwide veterinary oncology market is predicted to broaden at a high-value CAGR of 12% and attain a valuation of US$ 800 million by the tip of 2033.
Veterinary oncology pertains to the care supplied to pets identified with most cancers, aiming to enhance their total high quality of life. Among companion animals, most cancers ranks as the first explanation for mortality, with pores and skin most cancers and bone most cancers being most prevalent in dogs and cats. Skin most cancers, largely attributed to steady solar publicity in home animals, stands as probably the most generally identified most cancers sort. In making therapy selections for circumstances like most cancers, veterinarians collaborate with pet homeowners and make use of the HHHHHMM scale to evaluate the pet’s high quality of life.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8946
The market is increasing considerably, largely on account of the rising incidence of pet most cancers and the increasing use of veterinary most cancers remedy as a type of therapy. This progress is additional fueled by the rising prices of veterinary therapy in industrialized nations, as pet homeowners are more and more able to spend money on the well being of their animals. Government packages focused at enhancing veterinary most cancers care are additionally aiding market progress.
There are extra veterinary medical research being performed to guage the efficacy and security of quite a lot of most cancers drugs, which bodes properly for the longer term progress of the veterinary oncology market.
-
The Pre-Medical Cancer Immunotherapy Network of Canine Trials and comparative oncology packages had been credited with taking part in a vital half within the execution of trials of cutting-edge remedies for a lot of types of pet cancers, together with canine cancers, in line with a 2020 National Cancer Institute evaluation.
|
Report Attributes |
Details |
|
Value Projection (2033) |
US$ 800 Million |
|
Growth Rate (2023-2033) |
12% CAGR |
|
No. of Pages |
170 pages |
|
No. of Tables |
30 Tables |
|
No. of Figures |
127 Figures |
Key Takeaways from Market Study
-
The world marketplace for veterinary oncology is valued at US$ 260 million in 2023.
-
Worldwide demand for veterinary oncology is predicted to extend at a noteworthy CAGR of 12% via 2033.
-
By the tip of 2033, the market is projected to succeed in US$ 800 million.
-
The chemotherapy class accounted for a number one income share of 25% in 2023.
-
Due to rising incidence of the illness in pets, significantly dogs, the lymphoma most cancers sort section dominated the marketplace for veterinary oncology and accounted for the largest income share of 39% in 2023.
-
With a forty five% market share in 2023, North America led the worldwide veterinary oncology market.
-
At a CAGR of 11.5%, the market in Asia Pacific is predicted to broaden sooner than others through the forecast interval.
-
From 2023 to 2030, the United States veterinary oncology market is projected to broaden at a compound annual progress charge (CAGR) of 6%.
-
The canine class holds probably the most substantial market share, accounting for 26% in 2023.
“Increased public awareness of the management and treatment of cancer in pets is anticipated to fuel the growth of the veterinary oncology market. During the projection period, expansion of veterinary clinical centers devoted to the creation of cutting-edge treatment solutions will also open attractive market opportunities,” says a Fact.MR analyst.
Key Companies Profiled in This Report
Market Competition
The subject of veterinary oncology is presently witnessing a heightened emphasis on most cancers remedies, main outstanding corporations throughout the sector to prioritize the innovation and launch of novel merchandise. The market shows a average degree of fragmentation, with quite a few companies actively collaborating on this area.
-
In November 2022, the University of Wisconsin School of Veterinary Medicine obtained a US$ 75,000 grant aimed toward delivering life-saving most cancers care to pets and their households. The grant will likely be disbursed to eligible purchasers on a first-come, first-served foundation, with a most quantity of US$ 4,000 per shopper.
What Does the Future Hold for Veterinary Oncology within the US?
“Growing Animal Population and More Government Support for Cancer Treatment”
The market within the United States is anticipated to develop at a CAGR of 6% between 2023 and 2030.
The marketplace for veterinary oncology in North America has constantly held a large share and is anticipated to proceed doing so at some stage in the forecast interval. This persevering with dominance may be attributed to quite a few issues, together with widespread pet possession, a rise in most cancers instances, the availability of top-notch veterinary care and providers, and the rising cost of veterinary healthcare within the space.
The United States Food and Drug Administration (FDA) granted Tanovea-CA1 (rabacfosadine for injection), a drug developed by Zoetis Inc. for the therapy of canine most cancers, approval on February 27, 2020. The firm’s most cancers product line has considerably expanded on account of this approval.
It is projected that the marketplace for veterinary oncology will likely be dominated by the US. This may be attributed to a number of components, together with the nation’s sizable animal inhabitants, excessive spending on animal medication compounding, and a pronounced prevalence of animal most cancers instances.
With a big 45% market share in 2023, North America dominated the veterinary oncology trade.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8946
More Valuable Insights on Offer
Fact.MR, in its new providing, presents an unbiased evaluation of the worldwide veterinary oncology market, presenting historic demand information for 2018 to 2022 and forecast statistics for 2023 to 2033.
The research divulges important insights into the market primarily based on remedy (radiology, chemotherapy, mixture remedy, immunotherapy, focused remedy), mode of administration (oral, intravenous), most cancers sort (lymphoma, mast cells, mammary & squamous cells), animal sort (canine, feline), and distribution channel (hospital pharmacies, authorities businesses, retail pharmacies), throughout 5 main areas of the world (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
Explore More Related Studies Published by Fact.MR Research:
Intravenous Equipment Market: The world intravenous tools market is valued at US$ 12.3 billion and is forecasted to broaden at a CAGR of 5.6% to succeed in US$ 16.1 billion by 2027.
Cancer Immunotherapy Market: The most cancers immunotherapy market is anticipated to succeed in almost US$ 310 Bn by 2031.
Radioimmunotherapy Market: Increasing adoption of focused are driving the radioimmunotherapy (RIT) market.
About Fact.MR:
Fact.MR is a distinguished market analysis firm famend for its comprehensive market reports and invaluable business insights. As a outstanding participant in business intelligence, we delivers deep evaluation, uncovering market developments, progress paths, and aggressive landscapes. Renowned for its dedication to accuracy and reliability, we empowers businesses with essential information and strategic suggestions, facilitating knowledgeable decision-making and enhancing market positioning. With its unwavering dedication to offering dependable market intelligence, FACT.MR continues to help corporations in navigating dynamic market challenges with confidence and reaching long-term success. With a world presence and a workforce of skilled analysts, FACT.MR ensures its purchasers obtain actionable insights to capitalize on rising alternatives and keep forward within the aggressive panorama.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: [email protected]
Follow Us: LinkedIn | Twitter | Blog
